Oak Grove Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,250
Closed -$214K 93
2021
Q4
$214K Sell
1,250
-125
-9% -$20.5K 0.04% 90
2021
Q3
$222K Hold
1,375
0.05% 86
2021
Q2
$227K Sell
1,375
-10
-0.7% -$1.66K 0.05% 89
2021
Q1
$228K Buy
1,385
+15
+1% +$2.43K 0.06% 79
2020
Q4
$216K Buy
+1,370
New +$202K 0.07% 64
2019
Q2
Sell
-3,550
Closed -$496K 72
2019
Q1
$496K Buy
3,550
+1,050
+42% +$141K 0.31% 51
2018
Q4
$323K Buy
2,500
+1,950
+355% +$272K 0.29% 49
2018
Q3
$76K Sell
550
-800
-59% -$106K 0.07% 68
2018
Q2
$164K Buy
1,350
+500
+59% +$62.4K 0.17% 46
2018
Q1
$109K Sell
850
-4,500
-84% -$608K 0.12% 52
2017
Q4
$748K Buy
+5,350
New +$745K 0.78% 30

Other funds holding JNJ

Oak Grove Capital's JNJ Position: Q1 2022 in Review

Oak Grove Capital sold out of Johnson & Johnson (JNJ) in Q1 2022, closing a stake of 1,250 shares — an estimated $214K sold.

Oak Grove Capital first reported a position in JNJ in Q4 2017 and held it in 11 quarters. The position peaked at $748K in Q4 2017. 3,676 funds tracked by Wall St. Rank hold JNJ as of Q1 2022.

  • Oak Grove Capital reported no remaining Johnson & Johnson position as of Q1 2022 after selling out during the quarter.
  • Oak Grove Capital sold 1,250 Johnson & Johnson shares in Q1 2022, an estimated $214K.
  • Oak Grove Capital first reported a position in Johnson & Johnson in Q4 2017 and held it in 11 quarters.
  • Oak Grove Capital's Johnson & Johnson position peaked at $748K in Q4 2017.
  • 3,676 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2022.

Based on Oak Grove Capital's 13F filing for Q1 2022, filed 10 May 2022.